← Back to Search

Ultrasound-Guided Pressure Measurement for Liver Disease

N/A
Recruiting
Led By Prashant Kedia, MD
Research Sponsored by Methodist Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Summary

This trial aims to see how well and safely a new method called Endoscopic Ultrasound (EUS) Portal Pressure Gradient Measurement (PPGM) works in patients getting liver biopsies using EUS

Who is the study for?
This trial is for individuals with liver disease who are already scheduled to have an endoscopic ultrasound-guided liver biopsy. Specific eligibility details aren't provided, but typically participants should meet certain health standards and not have conditions that could interfere with the study or their safety.
What is being tested?
The trial is testing a procedure called Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement (EUS-PPGM) during routine liver biopsies in patients with liver disease to assess its safety and effectiveness.
What are the potential side effects?
While specific side effects of EUS-PPGM are not listed, potential risks may include discomfort, bleeding, infection at the biopsy site, or rare complications related to endoscopy such as perforation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Portal Pressure Gradient Measurements from Hepatic and Portal Veins
Secondary outcome measures
Clinical significance between portal pressure gradient measurement and portal hypertension
Correlation between Portal Pressure Gradient Measurements and the presence or absence of portal hypertension

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Patients undergoing Endoscopic-Ultrasound Guided liver biopsies and Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurements

Find a Location

Who is running the clinical trial?

Methodist Health SystemLead Sponsor
152 Previous Clinical Trials
4,825,533 Total Patients Enrolled
Prashant Kedia, MDPrincipal InvestigatorMethodist Dallas Medical Center
8 Previous Clinical Trials
996 Total Patients Enrolled
~6 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top